Pages that link to "Q35188406"
Jump to navigation
Jump to search
The following pages link to Uptake of cystic fibrosis testing in primary care: supply push or demand pull? (Q35188406):
Displaying 50 items.
- Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease (Q24187920) (← links)
- Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations (Q24599256) (← links)
- Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening (Q24676322) (← links)
- Preconception care: promoting reproductive planning (Q27012593) (← links)
- Common methods of measuring 'informed choice' in screening participation: Challenges and future directions (Q28069573) (← links)
- The impact of population based screening for carriers of cystic fibrosis (Q33674134) (← links)
- The genetic testing of children. Working Party of the Clinical Genetics Society (UK) (Q33675283) (← links)
- Direct marketing of cystic fibrosis carrier screening: commercial push or population need? (Q33676330) (← links)
- The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. (Q33678935) (← links)
- The new genetics: Psychological responses to genetic testing (Q33789196) (← links)
- The new genetics: Implications for clinical services in Britain and the United States (Q33789302) (← links)
- The challenge of integrating genetic medicine into primary care (Q33805196) (← links)
- Evaluation of questionnaire on cancer family history in general practice. Principal role of primary care is not to seek out those at increased genetic risk (Q33820578) (← links)
- The ethics and impact on behaviour of knowledge about one's own genome. Interview by Judy Jones (Q33821414) (← links)
- The views of general practitioners on community carrier screening for cystic fibrosis (Q34054830) (← links)
- Increasing informed uptake and non-uptake of screening: evidence from a systematic review (Q34255346) (← links)
- Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases (Q34399100) (← links)
- Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews (Q34677322) (← links)
- Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria (Q34781236) (← links)
- Preconceptional genetic carrier testing and the commercial offer directly-to-consumers (Q34815598) (← links)
- Screening for carriers of cystic fibrosis--a general practitioner's perspective (Q35189651) (← links)
- Costs, effects, and savings of screening for cystic fibrosis gene carriers (Q35558387) (← links)
- Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making. (Q35700083) (← links)
- Cystic fibrosis heterozygote screening in 5,161 pregnant women (Q35881825) (← links)
- Cystic fibrosis carrier population screening in the primary care setting (Q35882814) (← links)
- Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. (Q35889480) (← links)
- Carrier screening in preconception consultation in primary care (Q36164703) (← links)
- Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test (Q36426689) (← links)
- Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.? (Q36697785) (← links)
- Active cascade testing for carriers of cystic fibrosis gene (Q36885761) (← links)
- Antenatal screening for cystic fibrosis: a trial of the couple model (Q36885781) (← links)
- Screening for carriers of cystic fibrosis. Psychological consequences are unclear (Q36887616) (← links)
- Screening for carriers of cystic fibrosis. Screening before pregnancy is needed (Q36887642) (← links)
- Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening (Q36902278) (← links)
- Responsible implementation of expanded carrier screening (Q36902740) (← links)
- A measure of informed choice. (Q37331258) (← links)
- Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature. (Q37471817) (← links)
- Consanguineous marriage and reproductive risk: attitudes and understanding of ethnic groups practising consanguinity in Western society (Q37636712) (← links)
- Ethical considerations in choosing a model for population‐based cystic fibrosis carrier screening (Q37777161) (← links)
- Screening for major diseases in community pharmacies: a systematic review. (Q38107551) (← links)
- Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. (Q38136985) (← links)
- Genetic advances in cystic fibrosis: to screen, to treat or both? (Q38477273) (← links)
- Update and Review: Cystic Fibrosis (Q38542676) (← links)
- Carrier screening in the community (Q40379277) (← links)
- Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer. (Q40453081) (← links)
- Techniques in current use in prenatal diagnosis. (Q40584410) (← links)
- How men view genetic testing for prostate cancer risk: findings from focus groups (Q40738981) (← links)
- Cystic fibrosis: inheritance, genetics and treatment (Q40903810) (← links)
- Screening for Risk Factors for Cardiovascular Disease: A Psychological Perspective (Q41723297) (← links)
- Screening for carriers of cystic fibrosis (Q42581974) (← links)